Home Neoplasma 2017 Neoplasma Vol.64, No.2, p.278-282, 2017

Journal info


6 times a year.
Founded: 1954
ISSN 0028-2685
ISSN 1338-4317 (online)

Published in English

Editorial Info
Abstracted and Indexed
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Neoplasma Vol.64, No.2, p.278-282, 2017

Title: Absence of BRAF mutation in pheochromocytoma and paraganglioma
Author: T. VOSECKA, A. VICHA, T. ZELINKA, P. JENCOVA, K. PACAK, J. DUSKOVA, J. BENES, A. GUHA, L. STANEK, M. KOHOUTOVA, Z. MUSIL

Abstract: Pheochromocytomas and Paragangliomas (PHEO/PARA) are rare endocrine tumors originating from the adrenal medulla. More than 20 genes are involved in the tumorigenesis of these tumors, but a substantial part of the causative genetic events remains unexplained. A recent study has reported the presence of the activating BRAF V600E mutation in PCC, suggesting a role for BRAF activation in tumor development. Other studies have not find this mutation. This study investigates the occurrence of the BRAF V600E mutation in these tumors.
A cohort of 64 PHEO/PARA were screened for the BRAF V600E mutation using direct Sanger sequencing and QRT-PCR.
All cases investigated displayed wild-type without V600E BRAF mutation
Taken together with all previously screened tumors up to date, only 1 V600E BRAF mutation has been found among 427 PCCs. These findings imply that the V600E BRAF mutation is a rare event in PHEO/PARA.

Keywords: pheochromocytoma, paraganglioma, BRAF, mutation
Published online: 14-Mar-2017
Year: 2017, Volume: 64, Issue: 2 Page From: 278, Page To: 282
doi:10.4149/neo_2017_215


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.